Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 6/20 | 0.54 |
| ▸ | ALB | P02768 | 2/20 | 0.53 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.49 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.49 |
| ▸ | KCNK2 | O95069 | 4/20 | 0.48 |
| ▸ | KCNK10 | P57789 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | SERPINE1 | P05121 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6833748 | 0.88 | ALB (0.51) | PLK1ALBSIRT2MCL1BCL2A1 | |
| SCHEMBL6833313 | 0.87 | ALB (0.44) | PLK1ALBSIRT2MCL1BCL2A1 | |
| SCHEMBL6360650 | 0.87 | KMT2A (0.57) | PLK1ALBSIRT2MCL1BCL2A1 | |
| SCHEMBL6359401 | 0.85 | ALB (0.63) | ALBKMT2AMEN1MAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL6821748 | 0.83 | ALB (0.70) | PLK1ALBKMT2AMEN1HTT | |
| SCHEMBL6346687 | 0.82 | ALB (0.60) | ALBKMT2AMEN1MAPTALDH1A1 | |
| SCHEMBL6359036 | 0.82 | MEN1 (0.66) | PLK1ALBKMT2AMEN1MAPT | |
| SCHEMBL6347792 | 0.82 | KCNK2 (0.67) | PLK1MCL1BCL2A1KCNK2KCNK10 | |
| SCHEMBL6359300 | 0.81 | ALB (0.53) | PLK1ALBKMT2AMEN1MAPT | |
| SCHEMBL6353963 | 0.81 | KMT2A (0.62) | ALBMCL1BCL2A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050113450-A1 | Antibacterial agents | PHARMACIA & UPJOHN COMPANY | 2005-05-26 | — | — | US | claimed |
| WO-2004018414-A2 | ANTIBACTERIAL AGENTS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113450-A1 | Antibacterial agents | CLPP, SPOUT1, SAMHD1 | PLK1 3959/4885ALB 1682/4885SIRT2 3380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.